Spyre Therapeutics (SYRE) stock analysis: de-risked pipeline, cash runway to H2 2028, and 2026–2027 Phase 2 catalysts in ...

Software supply chain attacks are evolving as open source and AI-generated code introduce new third-party risks. Learn how visibility and shift-left security reduce exposure.

The "TrendSights Analysis 2025: Self-Reliance" report has been added to ResearchAndMarkets.com's offering.

CAMP4 signs ASO collaboration with GSK, securing $17.5 million upfront as analysts reaffirm Outperform and highlight 2026 ...

Intel's 2026 turnaround relies on AI trends, foundry growth, and competitive products. Learn what's at stake and what this ...

In the pharmaceutical discovery process, understanding a drug’s residence time—the duration a molecule remains bound to its ...

IOI Corporation Berhad (“IOI”) announced that its near-term greenhouse gas (GHG) emissions reduction targets have been ...

An indicted member of Congress topped one watchdog’s list of top ethics violators of 2025 that also includes nonprofits and ...

Although wastewater surveillance can enhance knowledge about the circulation of pathogens, some European states question the ...

A research paper by scientists at the Beijing Institute of Technology proposed a brain–machine hybrid intelligent system for sound target detection (STD), featuring a neuroanatomy-informed EEG ...

A new imaging technology can distinguish cancerous tissue from healthy cells by detecting ultra-weak light signals. It relies ...

H.C. Wainwright reiterated a Buy rating and $20 price target on Omeros (OMER) following the FDA approval of Yartemlea for hematopoietic stem cell ...